Skip to content

Clinical trials

Trials in Belarus with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Not applicable Country / region: Belarus Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20132
20142
20152
20171
20191
20202
20211
20226
20241
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status9
Completed8
Recruiting4
Active, not recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mogilev Regional Clinical Hospital5
Ancora Heart, Inc.2
Federal Research Institute of Pediatric Hematology, Oncology and Immunology2
Gomel State Medical University2
Republican Scientific and Practical Center for Organ and Tissue Transplantation2
AVVA Pharmaceuticals Ltd.1
Belarusian State Medical University1
Center Of Phlebology1
Harvard Pilgrim Health Care1
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathies2
Heart Failure2
Precursor Cell Lymphoblastic Leukemia-Lymphoma2
Shock2
Alcoholic Intoxication1
Aortic Valve Stenosis1
Asthma1
COVID-191
Cardiomyopathy, Dilated1
Coma1

Trials

Showing 76 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.